Glimigrand-MV 2.3 Tablet SR
Marketer
D Earth Pharmaceuticals Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimigrand-MV 2.3 Tablet SR
Diabetex-Duo 2.3 SR tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. They help regulate blood glucose. Diabetex-Duo 2.3 SR should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary foods or juice). Alcohol should be avoided due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Prior heart disease should be disclosed to your physician before initiating treatment. Pregnant or breastfeeding individuals require medical consultation before use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.
Uses of Glimigrand-MV 2.3 Tablet SR
Managing type 2 diabetes
Major Benefits of Glimigrand-MV 2.3 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Administer Glimigrand-MV 2.3 Tablet SR on an empty stomach.
Common Side effects of Glimigrand-MV 2.3 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimigrand-MV 2.3 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimigrand-MV 2.3 Tablet SR on an empty stomach.
How Glimigrand-MV 2.3 Tablet SR works:
Glimigrand-MV 2.3 extended-release tablets contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimigrand-MV 2.3 Tablet SR and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimigrand-MV 2.3 Tablet SR during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Consult your physician for guidance.
Breast feedingCONSULT YOUR DOCTOR
The sustained-release Glimigrand-MV 2.3 mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk with a risk of infant harm.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience such symptoms.
KidneyUNSAFE
The use of Glimigrand-MV 2.3 SR tablets is likely unsafe for individuals with kidney impairment and should be avoided. Medical advice is recommended. Furthermore, this medication is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimigrand-MV 2.3 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimigrand-MV 2.3 Tablet SR :
Should you forget a Glimigrand-MV 2.3 Tablet SR dose, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimigrand-MV 2.3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently